Concepedia

Ulrich Behre

UB

23

Publications

1.1K

Citations

17

H-Index

1997

Active since

Affiliations

University of Applied Sciences Kehl(Current)

GlaxoSmithKline (Belgium)

GlaxoSmithKline (India)

GlaxoSmithKline (United Kingdom)

Stiftung Juliusspital

Ulrich Behre is an author at University of Applied Sciences Kehl specializing in medicine, vaccination, and vaccine development.

Top concepts

Publications per year

1997–2019

23

Publications

23

Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

James Hedrick, Asher Barzilai, Ulrich Behre et al. · The Pediatric Infectious Disease Journal · 2000 · 244 citations

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson et al. · Human Vaccines & Immunotherapeutics · 2014 · 99 citations · Full text

, , +17

RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe

Timo Vesikari, Robbin Itzler, Aino Karvonen et al. · Vaccine · 2009 · 98 citations

, , +6

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study

Barbara Romanowski, Tino F. Schwarz, Linda Ferguson et al. · Human Vaccines & Immunotherapeutics · 2015 · 93 citations · Full text

Immunogenicity and Reactogenicity of Four Doses of Diphtheria-Tetanus-Three-Component Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae Type b Vaccine Coadministered with 7-Valent Pneumococcal Conjugate Vaccine

Irmingard Tichmann-Schumann, Peter Soemantri, Ulrich Behre et al. · The Pediatric Infectious Disease Journal · 2005 · 88 citations

Rows per page

1–5 of 23